0001808246-20-000003.txt : 20201029 0001808246-20-000003.hdr.sgml : 20201029 20201028205246 ACCESSION NUMBER: 0001808246-20-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201029 DATE AS OF CHANGE: 20201028 EFFECTIVENESS DATE: 20201029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Galvanize Therapeutics, Inc. CENTRAL INDEX KEY: 0001808246 IRS NUMBER: 845112839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-364148 FILM NUMBER: 201270181 BUSINESS ADDRESS: STREET 1: 1531 INDUSTRIAL RD CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-268-4252 MAIL ADDRESS: STREET 1: 1531 INDUSTRIAL RD CITY: SAN CARLOS STATE: CA ZIP: 94070 D/A 1 primary_doc.xml X0708 D/A LIVE 0001808246 Galvanize Therapeutics, Inc. 1531 INDUSTRIAL RD SAN CARLOS CA CALIFORNIA 94070 650-268-4252 DELAWARE None None Corporation true 2020 Jonathan Waldstreicher c/o Galvanize Therapeutics, Inc. 155 Jefferson Street, Suite 100 Menlo Park CA CALIFORNIA 94025 Executive Officer Director Seth Harrison c/o Galvanize Therapeutics, Inc. 155 Jefferson Street, Suite 100 Menlo Park CA CALIFORNIA 94025 Director Biotechnology Decline to Disclose 06b true 0001808246-20-000001 2020-03-20 false true false 0 16100863 6100863 10000000 $6,000,000 new money; $100,863 conversion of note false 1 0 0 0 false Galvanize Therapeutics, Inc. /s/ Jonathan Waldstreicher Jonathan Waldstreicher President & CEO 2020-10-28